# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-16-016664
Filing Date
2016-09-09
Accepted
2016-09-09 17:13:24
Documents
70
Period of Report
2016-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ANNUAL REPORT | f10k2016_relmadatherap.htm | 10-K | 1209707
2 | AGREEMENT DATED, SEPTEMBER 98, 2016, BY AND BETWEEN SHREERAM AGHARKAR AND RELEMA | f10k2016ex10xxv_relmada.htm | EX-10.25 | 107054
3 | LIST OF SUBSIDIARIES (INCORPORATED BY REFERENCE TO EXHIBIT 21.1 OF RELMADA'S FOR | f10k2016ex21i_relmada.htm | EX-21.1 | 1230
4 | CERTIFICATION | f10k2016ex31i_relmada.htm | EX-31.1 | 10770
5 | CERTIFICATION | f10k2016ex31ii_relmada.htm | EX-31.2 | 10679
6 | CERTIFICATION | f10k2016ex32i_relmada.htm | EX-32.1 | 5686
7 | CERTIFICATION | f10k2016ex32ii_relmada.htm | EX-32.2 | 5821
| Complete submission text file | 0001213900-16-016664.txt |  | 4757810

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL INSTANCE FILE | rlmd-20160630.xml | EX-101.INS | 713482
9 | XBRL SCHEMA FILE | rlmd-20160630.xsd | EX-101.SCH | 43265
10 | XBRL CALCULATION FILE | rlmd-20160630_cal.xml | EX-101.CAL | 40462
11 | XBRL DEFINITION FILE | rlmd-20160630_def.xml | EX-101.DEF | 189862
12 | XBRL LABEL FILE | rlmd-20160630_lab.xml | EX-101.LAB | 427453
13 | XBRL PRESENTATION FILE | rlmd-20160630_pre.xml | EX-101.PRE | 306227

Mailing Address 275 MADISON AVENUE, SUITE 702 NEW YORK NY 10016
Business Address 275 MADISON AVENUE, SUITE 702 NEW YORK NY 10016 646-677-3853
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-55347 | Film No.: 161879450
SIC: 2834 Pharmaceutical Preparations